These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8649622)

  • 1. Does the modality of haemodialysis treatment affect lipoprotein composition?
    Blankestijn PJ; Joles JA; Koomans HA
    Nephrol Dial Transplant; 1996 Jan; 11(1):14-6. PubMed ID: 8649622
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renal dyslipidemia in patients on chronic hemodialysis].
    Kovacić V; Sain M; Vukman V
    Lijec Vjesn; 2003; 125(3-4):77-80. PubMed ID: 12899098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia in chronic renal failure patients.
    Almeida AF; Gunjotikar RV; Chitalia V
    J Postgrad Med; 1994; 40(2):52-4. PubMed ID: 8737550
    [No Abstract]   [Full Text] [Related]  

  • 5. Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis.
    Cattran DC; Fenton SS; Wilson DR; Steiner G
    Ann Intern Med; 1976 Jul; 85(1):29-33. PubMed ID: 937920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes of coronary heart disease in patients on renal replacement therapy.
    Wanner C; Zimmermann J
    Kidney Blood Press Res; 1998; 21(2-4):287-9. PubMed ID: 9762860
    [No Abstract]   [Full Text] [Related]  

  • 7. Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation.
    Nishizawa Y; Shoji T; Kawagishi T; Morii H
    Kidney Int Suppl; 1997 Nov; 62():S90-2. PubMed ID: 9350691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Causes and risks of hyperlipidemia during dialysis and after renal transplantation].
    Verzola A; Perini L; Gatto S; Gilli P; Bedani PL
    Recenti Prog Med; 1998 Nov; 89(11):590-7. PubMed ID: 9844447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disorders of blood-lipids in renal disease.
    Cramp DG; Moorhead JF; Wills MR
    Lancet; 1975 Mar; 1(7908):672-3. PubMed ID: 47091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia in patients with chronic renal failure and in renal transplant patients.
    Shah B; Nair S; Sirsat RA; Ashavaid TF; Nair KG
    J Postgrad Med; 1994; 40(2):57-60. PubMed ID: 8737552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients.
    Wanner C; Zimmermann J; Quaschning T; Galle J
    Kidney Int Suppl; 1997 Nov; 62():S53-5. PubMed ID: 9350681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipoprotein patterns in patients receiving dialysis therapy for chronic renal failure.
    Cramp DG; Tickner TR; Varghese Z; Beale DJ; Moorhead JF; Wills MR
    Clin Chim Acta; 1977 Apr; 76(2):233-6. PubMed ID: 862197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of tunnelled haemodialysis catheters at the start of haemodialysis--success rates and definition of infection.
    Aslam N; Lambie M; Ayub V; Stein A
    Nephrol Dial Transplant; 2007 Jun; 22(6):1799-800. PubMed ID: 17389620
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperhomocysteinemia in chronic renal failure].
    Sydor A; Sułowicz W
    Przegl Lek; 1999; 56(7-8):520-4. PubMed ID: 10575921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What are the possibilities for treatment of hyperlipidemia in kidney insufficiency or in dialysis patients?].
    Grützmacher P; Scheuermann E
    Med Welt; 1982 Jun; 33(24):873-4. PubMed ID: 7109928
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic kidney failure, hyperproteinemia and vascular risk].
    Rubiés-Prat J
    Med Clin (Barc); 1984 Jun; 83(4):173-5. PubMed ID: 6482569
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipaemic profile of patients subjected to long-term haemodialysis and acute changes associated with haemodialysis and the use of heparin (author's transl)].
    Koslík S; Takác M
    Sb Lek; 1981 Jul; 83(6-7):162-8. PubMed ID: 7268304
    [No Abstract]   [Full Text] [Related]  

  • 20. Are biocompatible membranes superior for hemodialysis therapy?
    van Ypersele de Strihou C
    Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.